Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
Nature Medicine2013Vol. 19(3), pp. 329–336
Citations Over TimeTop 1% of 2013 papers
Jeong Heo, Tony Reid, Leyo Ruo, Caroline J. Breitbach, Steven C. Rose, Mark Bloomston, Mong Cho, Ho Yeong Lim, Hyun Cheol Chung, Chang Won Kim, James M. Burke, Riccardo Lencioni, Theresa Hickman, Anne Moon, Yeon Sook Lee, Hyun Kyoung Kim, Manijeh Daneshmand, Kara Dubois, Lara Longpre, Minhtran Ngo, Cliona M. Rooney, John C. Bell, Byung-Geon Rhee, Richard H. Patt, Tae-Ho Hwang, David H. Kirn
Related Papers
- → The mechanisms of genetically modified vaccinia viruses for the treatment of cancer(2015)31 cited
- → Oncolytic Vaccinia Virus: A Theranostic Agent for Cancer(2010)28 cited
- → Anti‐tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies(2014)8 cited
- Advances of Oncolytic Vaccinia Virus for the Treatment of Tumor(2012)
- → Oncolytic vaccinia virus: a promising agent for cancer treatment(2016)